Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-01-05
1997-05-13
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3138
Patent
active
056293372
ABSTRACT:
Methods are disclosed utilizing optically pure (-)-zileuton for the treatment of asthma in humans while substantially reducing the concomitant liability of adverse effects associated with the racemic mixture of zileuton.
REFERENCES:
patent: 4873259 (1989-10-01), Summers, Jr. et al.
Bell et al. "The Discovery and Development of Zileuton: An Orally Active 5-Lipoxygenase Inhibitor" Int. J. Immunopharmac. 14, 505-510 (1992).
Carter et al. "5-Lipoxygenase Inhibitory Activity of Zileuton" J. Phar. and Exp. Ther. 256, 929-937 (1990).
Hsiao et al. "Synthesis of Chiral Zileuton, A Potent and Selective Inhibitor of 5-Lipoxygenase" Tet. Ltrs. 33, 2629-2632 (1992).
Sweeny et al. "Enantiomeric Activation of Glucronidation in Dog Hepatic Microsomes" J. Biol. Chem. 267, 13171-13174 (1992).
Siris et al. "Effect of Zileuton (A-64077) on the 5-Lipoxygenase activity of human whole blood ex vivo" Agents and Actions, 34, 117-120 (1991).
Weinblatt et al. "Zileuton, A 5-Lipoxygenase Inhibitor in Rheumatoid Arthritis" J. Rheum. 19, 1537-1541 (1992).
Laursen et al. "Selective 5-lipoxygenase inhibition in ulcerative colitis" Lancet 335, 683-685 (1990).
Israel et al. "The Effects of a 5-Lipoxygenase Inhibitor on Asthma Induced By Cold, Dry Air" N. Eng. J. Med. 323, 1740-1744 (1990).
Collawn et al. "Phase II Study of the Safety and Efficacy of a 5-Lipoxygenase Inhibitor in Patients with Ulcerative Colitis" Amn. J. Gastro. 87, 342-346 (1992).
Knapp "Reduced Allergen-Induced Nasal Congestion and Leukotriene Synthesis With An Orally Active 5-Lipoxygenase Inhibitor" N. Eng. J. Med. 323, 1745-1748 (1990).
Cintins Marianne M.
Jarvis William R. A.
Sepracor Inc.
LandOfFree
Methods for treating asthma using optically pure (-)-zileuton does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treating asthma using optically pure (-)-zileuton, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating asthma using optically pure (-)-zileuton will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1385698